• <samp id="ossg8"></samp>
    <tbody id="ossg8"><nobr id="ossg8"></nobr></tbody>
    <menuitem id="ossg8"><strong id="ossg8"></strong></menuitem>
  • <samp id="ossg8"></samp>
    <menuitem id="ossg8"><strong id="ossg8"></strong></menuitem>
  • <menuitem id="ossg8"><ins id="ossg8"></ins></menuitem>

  • <tbody id="ossg8"><nobr id="ossg8"></nobr></tbody>
    <menuitem id="ossg8"></menuitem>
        Skip Navigation LinksSkip Navigation Links
        Centers for Disease Control and Prevention
        Safer Healthier People
        Blue White
        Blue White
        bottom curve
        CDC Home Search Health Topics A-Z spacer spacer
        spacer
        Blue curve MMWR spacer
        spacer
        spacer

        Summary Table. Rotavirus Vaccine for the Prevention of Rotavirus Gas Among Children Recommendations of the Advisory Committee on Immunization Practices (ACIP)

        Summary Table. Recommendations and Quality of Evidence

        Rotavirus Vaccine Recommendations Advisory Committee on Immunization Practices, 1999 (Table_1)
        Table_1
        Note: To print large tables and graphs users may have to change their printer settings to landscape and use a small font size.

        
        Summary Table. Recommendations and Quality of Evidence
        Rotavirus Vaccine Recommendations Advisory Committee on Immunization Practices, 1999
        =====================================================================================================================================
                                                                                                               Level of         Strength of
        Recommendations                                                                                       Evidence*          Evidence+
        -------------------------------------------------------------------------------------------------------------------------------------
        Provide routine vaccination at 2,4,and 6 months of age.                                                   I                  A
        Administer to breastfed infants.                                                                          I                  A
        Administer with DTP (or DTaP),Hib vaccine,OPV,IPV,and hepatitis B vaccine.                                I                  A
        Administer to infants with mild illnesses.                                                                I                  B
        Not recommended for
        Infants with known or suspected immunodeficiency                                                         III                 C
        Infants with hypersensitivity to vaccine components                                                      III                 B
        Infants with acute gastrointestinal disease                                                              III                 C
        Infants with moderate to severe febrile illness                                                          III                 C
        Precautions and special situations
        Premature infants (<37 weeks gestational age)                                                            III                 C
        Infants living in households with immunocompromised persons                                              III                 C
        Timing of administration of antibody-containing blood products and rotavirus vaccination                 III                 C
        Infants with preexisting chronic gastrointestinal illnesses                                              III                 C
        Vaccine that is regurgitated                                                                             III                 C
        Late or incomplete immunization                                                                          III                 C
        Children hospitalized after vaccination                                                                  III                 C
        -------------------------------------------------------------------------------------------------------------------------------------
        * Level of Evidence
        I Evidence from randomized, controlled trials
        II Evidence from other epidemiologic studies
        III Opinions of authorities
        
        + Strength of Evidence
        A Good evidence to support recommendation
        B Fair evidence to support recommendation
        C Insufficient evidence
        =====================================================================================================================================
        

        Return to top.

        Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

        **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

        Page converted: 03/18/99

        HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
        POLICY  |  DISCLAIMER  |  ACCESSIBILITY

        Safer, Healthier People

        Morbidity and Mortality Weekly Report
        Centers for Disease Control and Prevention
        1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

        USA.GovDHHS

        Department of Health
        and Human Services

        This page last reviewed 5/2/01




        国产精品久久久久久一级毛片